205 related articles for article (PubMed ID: 12843914)
1. [Questions to Professor Jean-François Bretagne].
Bretagne JF
Gastroenterol Clin Biol; 2003 May; 27(5):518-21. PubMed ID: 12843914
[No Abstract] [Full Text] [Related]
2. The coxibs, selective inhibitors of cyclooxygenase-2.
Rich SA
N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
[No Abstract] [Full Text] [Related]
3. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
Zaragoza A; Llorente MJ; García MM; Ramírez JJ; Lloret G; Machancoses A
Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
[No Abstract] [Full Text] [Related]
4. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
Baigent C; Patrono C
Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
[No Abstract] [Full Text] [Related]
5. [Selective inhibitors of cyclooxigenase-2 (Coxibs) and cardiovascular morbidity].
Ruilope LM; Coca A
Med Clin (Barc); 2002 Feb; 118(6):219-21. PubMed ID: 11864545
[No Abstract] [Full Text] [Related]
6. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
Bannwarth B
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
[No Abstract] [Full Text] [Related]
7. Coxibs and cardiovascular disease.
Fitzgerald GA
N Engl J Med; 2004 Oct; 351(17):1709-11. PubMed ID: 15470192
[No Abstract] [Full Text] [Related]
8. [Dyspepsia and non-steroidal anti-inflammatory agents: not everything is an ulcer].
Lanas A; Arroyo MT
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():25-30. PubMed ID: 11968331
[No Abstract] [Full Text] [Related]
9. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
[No Abstract] [Full Text] [Related]
10. [Mechanism of inhibition OF COX-2 and COX-3 in gastrointestinal damage induced by NSAID in rats ].
Laudanno OM; San Miguel P; Aramberry LJ; Cesolari JA
Acta Gastroenterol Latinoam; 2003; 33(4):183-5. PubMed ID: 14708469
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
Palmer RH
JAMA; 2000 Apr; 283(15):1961-2. PubMed ID: 10789662
[No Abstract] [Full Text] [Related]
12. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
Fernandez H; Lesser GT
JAMA; 2000 Apr; 283(15):1961; author reply 1962. PubMed ID: 10789661
[No Abstract] [Full Text] [Related]
13. The coxibs, selective inhibitors of cyclooxygenase-2.
Nzerue CM
N Engl J Med; 2001 Dec; 345(23):1708-9. PubMed ID: 11759655
[No Abstract] [Full Text] [Related]
14. Cardiovascular events and COX-2 inhibitors.
White WB; Whelton A
JAMA; 2001 Dec; 286(22):2811-2. PubMed ID: 11735749
[No Abstract] [Full Text] [Related]
15. Cardiovascular events and COX-2 inhibitors.
Konstam MA; Demopoulos LA
JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735743
[No Abstract] [Full Text] [Related]
16. COX 2 inhibition and bowel strictures.
Maiden LP; Bjarnason I
Gut; 2004 Jul; 53(7):1057-8. PubMed ID: 15194667
[No Abstract] [Full Text] [Related]
17. Cardiovascular events and COX-2 inhibitors.
Grant KD
JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735744
[No Abstract] [Full Text] [Related]
18. [COX-2 specific inhibitors are similar--and different].
Aly A
Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
[No Abstract] [Full Text] [Related]
19. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study.
Mamdani M; Juurlink DN; Kopp A; Naglie G; Austin PC; Laupacis A
BMJ; 2004 Jun; 328(7453):1415-6. PubMed ID: 15138157
[No Abstract] [Full Text] [Related]
20. [A new class of nonsteroidal anti-inflammatory agents: COXIBs].
Costantino S
Clin Ter; 2003; 154(1):5-6. PubMed ID: 12854276
[No Abstract] [Full Text] [Related]
[Next] [New Search]